. .
shares of Curis Inc. .
CRIS,
372. 92%
Tuesday more than tripled to top all market players with the highest volume after the biotech company announced positive preliminary data from a Phase 1 study of its leukemia treatment. The stock rose 256. 3%, which puts them on the right track to open at the highest price seen during regular session hours since March 2018. The trading volume rose to 42. 5 million shares, compared to the all-day average of about 1. 7 million shares. According to Curis, CA-4948 monotherapy was well tolerated in adult patients, has shown signs of biological activity in the ongoing study, and is able to achieve « relevant drug exposure levels ». « The stock lost 15. 3% year-to-date through Monday, during the iShares Nasdaq Biotechnology ETF
IBB,
0. 69%
has climbed 22. 7% and the S&P 500
SPX,
0. 10%
won 14. 3%.
Tomi Kilgore is MarketWatch’s assistant editor for investments and corporate news and is based in New York. You can follow him on Twitter @TomiKilgore.
By using this website you agree to this
Subscriber Agreement & Terms of Use,
Privacy Policy and
Cookie Notice.
Intraday data is provided by FACTSET and is subject to the terms of use.
Historical and current end-of-day data from FACTSET.
All offers are in local exchange time.
Last real-time sales data for U. . S.. . Stock market prices only reflect trades reported through Nasdaq.
Intraday data was delayed by at least 15 minutes or as required by exchange.
Curis, Inc. . , NASDAQ: CRIS, Stock, NASDAQ, Leukemia
World News – US – Curis stocks have more than tripled on optimistic results from leukemia treatment study
. . Related title :
– Curis share more than tripling of massive volume after optimistic results of leukemia treatment
– Curis Skyrockets with positive phase -1 Lymphoma Treatment Test
– Curis (CRIS) stock rises to positive preliminary clinical data
– CRIS Stock News: Why Biotech Stock Curis are becoming gangbusters
– Form 8-K CURIS INC For: 07. December
– This Curis Cancer Study is a Great Success
– How volatile is Curis, Inc. . (CRIS) share?
– Curis Stock Skyrockets after positive preliminary CA-4948 data
– Curis Inc. . (NASDAQ: CRIS): Market capitalization reached $ 90. 07 million
– HC Wainwright increases the price target for Curis (NASDAQ: CRIS) to USD 9. 00
Ref: https://www.marketwatch.com
